Ackermann, Christoph; Kavanaugh, Arthur - In: PharmacoEconomics 26 (2008) 2, pp. 121-129
evaluations in PsA, driven mostly by the introduction of highly effective but expensive biologic agents, particularly inhibitors … of the proinflammatory cytokine tumour necrosis factor (TNF)-alpha. Treatment with TNFalpha inhibitors results in not … evaluations in the field of PsA. The notable clinical efficacy of the TNFalpha inhibitors needs to be factored into a …